Wen Xue
Impact in
- Cancer Research top 0.2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Aging top 0.5%
Papers in
-
- Cancer-related molecular mechanisms research 20
- MicroRNA in disease regulation 15
-
- CRISPR and Genetic Engineering 50
- RNA modifications and cancer 23
- RNA and protein synthesis mechanisms 21
- RNA Research and Splicing 19
- RNA regulation and disease 13
- RNA Interference and Gene Delivery 12
- Co-authors
- Lars ZenderScott W. LoweCarlos Cordon‐CardoValery KrizhanovskyEva HernandoGregory J. HannonRoss A. DickinsCornelius Miething
- Journals
- Nature Biotechnology (7 papers)Nature Communications (6 papers)Oncotarget (6 papers)Hepatology (5 papers)Nature (5 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Wen Xue
191 papers receiving 13.7k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Cancer Research 3.8k
- Aging 373
- Business and International Management 337
- Molecular Biology 10.7k
- Oncology 2.5k
Countries citing papers authored by Wen Xue
This map shows the geographic impact of Wen Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Xue more than expected).
Fields of papers citing papers by Wen Xue
This network shows the impact of papers produced by Wen Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Xue. The network helps show where Wen Xue may publish in the future.
Co-authors
The 25 scholars most cited alongside Wen Xue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 4 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 4 | |
| 9 | 2023 | 13 | |
| 10 | 2023 | 43 | |
| 11 | 2023 | 4 | |
| 12 | 2022 | 34 | |
| 13 | 2021 | 5 | |
| 14 | 2021 | 5 | |
| 15 | Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice Hit paper breakdown → | 2021 | 196 |
| 16 | 2017 | 235 | |
| 17 | Dendrimer-Inspired Nanomaterials for the in Vivo Delivery of siRNA to Lung Vasculature | 2014 | 5 |
| 18 | CRISPR-mediated direct mutation of cancer genes in the mouse liver | 2014 | 1 |
| 19 | 2011 | 109 | |
| 20 | Synergistic activation of eukaryotic gene transcription by multiple upstream sites | 2002 | 4 |
About Wen Xue
Wen Xue is a scholar working on Cancer Research, Molecular Biology, Business and International Management, Transplantation and Immunology, having authored 204 papers that have together received 13.9k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (50 papers), RNA modifications and cancer (23 papers), RNA and protein synthesis mechanisms (21 papers), Cancer-related molecular mechanisms research (20 papers), RNA Research and Splicing (19 papers), MicroRNA in disease regulation (15 papers), RNA regulation and disease (13 papers) and RNA Interference and Gene Delivery (12 papers). The work is most often cited by research in Cancer Research (3.8k citations), Aging (373 citations), Business and International Management (337 citations), Molecular Biology (10.7k citations) and Oncology (2.5k citations). Wen Xue has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Lars Zender, Scott W. Lowe, Carlos Cordon‐Cardo, Valery Krizhanovsky, Eva Hernando, Gregory J. Hannon, Ross A. Dickins, Cornelius Miething, Daniel G. Anderson and Tyler Jacks. Their work appears in journals such as Nature Biotechnology, Nature Communications, Oncotarget, Hepatology and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.